Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioblastoma 2 Polycystic Ovary Syndrome 1 Non-alcoholic Fatty Liver Disease 1 Multiple Myeloma 1 Fatty Liver 1 Estrogen Receptor-positive Breast Cancer 1 Breast Neoplasms 1 Adenocarcinoma of Lung 1

Interventions

Dexamethasone 124 Lenalidomide 72 daratumumab 71 Bortezomib 58 pomalidomide 47 carfilzomib 42 Cyclophosphamide 39 Calcium Dobesilate 36 Specimen Handling 31 Biopsy 29 Magnetic Resonance Spectroscopy 26 belantamab mafodotin 22 isatuximab 21 fludarabine 20 iberdomide 18 talquetamab 17 Melphalan 15 dexamethasone acetate 14 dexamethasone 21-phosphate 14 auricularum 14 fludarabine phosphate 13 elotuzumab 12 selinexor 10 tocilizumab 9 X-Rays 8 Nivolumab 8 trametinib 7 Whole-Body Irradiation 7 Sirolimus 7 Mycophenolic Acid 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Multiple Myeloma × Diet, Ketogenic × 90 days × Clear all

NCT07564219 2026-05-04

BEAM-MM

Universitätsklinikum Hamburg-Eppendorf

Phase NA Recruiting

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡